Septerna AAQS

Co robi Septerna? Septerna Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California. Listed on 25 October 2024, the firm engages in pioneering G protein-coupled receptor oral small molecule drug discovery powered by its proprietary Native Complex Platform. The company employs approximately 130 people and is developing novel therapeutic candidates across three key areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale platform targets specific GPCRs to uncover novel binding pockets and pursue diverse pharmacologies, including agonists, antagonists, and allosteric modulators. Septerna advances a deep portfolio of oral small molecule programs with unique mechanistic approaches to address significant unmet medical needs in these therapeutic fields. Septerna jest jedną z najpopularniejszych firm na Eulerpool.